Seminars in Oncology
Volume 36, Supplement 1 , Pages S52-S58, April 2009

Role of c-Met in Cancer: Emphasis on Lung Cancer

  • Ravi Salgia

      Affiliations

    • Corresponding Author InformationAddress correspondence to Ravi Salgia, MD, PhD, Department of Medicine, University of Chicago, Pritzker School of Medicine, 5841 S Maryland Ave, Chicago, IL 60637

Thoracic Oncology Research Program, University of Chicago, Pritzker School of Medicine, Chicago, IL

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 STATEMENT OF CONFLICT OF INTEREST: Dr Salgia reports serving on the Scientific Advisory Board for Cephalon and Biogen Idec, and as a Consultant for Merck.

 This work in part is supported by the NIH/NCI (2R01CA100750-05A1, 5R01CA125541-03, 1R01CA129501-01A1, 2P01HL058064-13), MARF (Jefferey P. Hayes Memorial), Cancer Research Foundation (Goldblatt Award) and V-Foundation (Guy Geelerd Memorial Foundation).

PII: S0093-7754(09)00036-0

doi:10.1053/j.seminoncol.2009.02.008

Seminars in Oncology
Volume 36, Supplement 1 , Pages S52-S58, April 2009

Article Tools

* Image Usage & Resolution